InvestorsHub Logo
Followers 10
Posts 212
Boards Moderated 0
Alias Born 04/26/2017

Re: zoomlik post# 838

Monday, 10/16/2017 4:44:53 PM

Monday, October 16, 2017 4:44:53 PM

Post# of 1954
Without having the benefit of hearing your convo and the way you presented the context 'the company is blinded' could mean numerous things in this setting, but it's not worth discussing. I will simple this down for ya. "Somebody" decided 108 patients is enough. So maybe Viking gave someone the authority to independently stop their study under certain conditions. Ok, maybe. Could interpret that many ways.
New line of thought. How'd they make that determination? Did they then flip some switch and a red light started blinking in the batcave (Viking headquarters). And since then, all Viking knew is that their study got triggered for early patient pool closure, which probably could only occur under really good or bad circumstances. So then they wait for months, and decide to pass the time by scheduling a KOL to talk about how much they love researching bone demineralization.
Anyways, outside of your one word answer- 'blinded' !!! that the clever chap in IR gave to another guy calling and asking about if they knew the results yet, which I commend you for picking up the phone, a lost art, what other information are you actually giving us here? And why'd ya buy stock recently if you feel that their sarm trial will result in catastrophic miscalculations in enrollment (avg phase II trial size = 100-500 pt). You could buy it way cheaper in a few weeks when the statistical significance monster emerges from its mountainside den, if you are so in love with the lipid drug and their selective ability to perform that trial well with 'statty sig'.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VKTX News